#YonhapInfomax #SKBioscience #Sanofi #PneumococcalVaccine #PCV21 #VaccineProductionFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=69860
SK Bioscience Holds Completion Ceremony for Andong Pneumococcal Vaccine Production Facility
SK Bioscience and Sanofi have completed an expanded pneumococcal vaccine production facility in Andong, strengthening their global partnership and advancing the launch of a next-generation 21-valent vaccine.